entertainment
Previous article:
The cancer drug shortage isn’t new — and neither are the solutions
Next article: Unicorn down: Following layoffs, Biofourmis CEO quietly departs
Next article: Unicorn down: Following layoffs, Biofourmis CEO quietly departs
hotspot
focus
-
Feds fine Medicare Advantage plans for overcharging members
2025-08-26 23:36 -
Neuroscience startup Neumora files for IPO
2025-08-26 22:32 -
In age of alternative facts, a scholarly course on calling out crap
2025-08-26 22:32 -
Why more medical students aren't specializing in primary care
2025-08-26 22:00 -
Appeals court upholds limits to abortion pill
2025-08-26 21:56 -
AstraZeneca challenges Medicare drug negotiation program
2025-08-26 21:15